To evaluate if altered PI3K signaling was BCR-specific, CD21pos B cells of HD, CD21pos and CD21low B cells of CVID patients were analyzed after incubation with CD40 ligand (CD40L) and CpG activating toll-like receptor 9 (TLR9). The gene discussed is BCR; the disease is Huntington disease.